Across TCGA pan-cancer cohorts, LINC02035 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC02035 data layer compared with 20 for mass-spec protein.
The strongest signal is observed in esophageal carcinoma (ESCA), where higher LINC02035 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02035 expression acts as an unfavorable survival marker.
ESCA are the cancer types where LINC02035 Mutation most reproducibly stratifies survival.